Does HLA matching matter in the modern era of renal transplantation?

Area of Science:

• Nephrology
• Transplantation immunology

Background:

• End-stage kidney disease (ESKD) in children necessitates optimal renal replacement therapy.
• Pre-emptive kidney transplantation offers the best long-term survival for pediatric patients.
• Global practices in pediatric kidney transplantation vary regarding donor sources and allocation strategies.

Purpose of the Study:

• To review the relative importance of human leukocyte antigen (HLA) matching versus donor quality in pediatric kidney transplantation.
• To evaluate long-term patient outcomes, including graft longevity and re-transplantation rates.
• To provide evidence-based guidance for clinicians and families in selecting optimal donor options for children.

Main Methods:

• Literature review of pediatric and adult kidney transplantation practices.
• Analysis of factors influencing graft survival, including HLA matching and donor characteristics.
• Discussion of outcomes in living donor versus deceased donor renal transplantation.

Main Results:

• Living donor kidney transplantation generally yields superior allograft survival outcomes.
• The significance of HLA matching may be diminishing with advancements in surgical techniques and immunosuppression.
• Donor quality and timely transplantation are critical for long-term graft and patient survival.

Conclusions:

• Optimizing donor selection, prioritizing living donation, and considering donor quality are crucial for pediatric kidney transplant success.
• Strategies for managing highly HLA-mismatched living donor scenarios require careful consideration.
• Further research is needed to refine guidelines for HLA matching in the context of modern transplant protocols.